Patient Summary:

The patient is a 45-year-old male who presents with a history of chronic back pain and left leg radiculopathy. The patient has a history of lumbar spine degenerative disc disease, facet joint hypertrophy, and spinal stenosis. The patient has tried conservative management including physical therapy and medications without significant relief. The patient is a candidate for lumbar spine fusion surgery.

Preoperative Medications:

The patient is currently taking the following medications:

* Omeprazole 20mg PO daily for gastroesophageal reflux disease
* Aspirin 81mg PO daily for prevention of cardiovascular disease
* Gabapentin 300mg PO tid for neuropathic pain
* Hydrocodone 10/325mg PO q4-6h PRN for pain

Preoperative Lab Results:

The patient's recent lab results are within normal limits, including:

* Complete Blood Count (CBC): WBC 4.8, Hb 13.2, Hct 40.8, Plt 201
* Electrolyte Panel: Na 138, K 4.2, Cl 102, CO2 24
* Lipid Panel: Total Chol 171, Trig 120, HDL 48, LDL 85
* Renal Function Panel: Creatinine 1.0, BUN 15
* Urinalysis: No protein, blood, or white blood cells seen

Preoperative Allergies:

The patient has no known allergies to medications or materials.

Preoperative History of Present Illness:

The patient presents with a several-year history of chronic back pain and left leg radiculopathy. The patient has tried conservative management including physical therapy and medications without significant relief. The patient's symptoms have progressively worsened over time, with difficulty ambulating and performing activities of daily living.

Preoperative Physical Exam:

On examination, the patient has tenderness to palpation over the lumbar spine with decreased sensation to light touch in the left L5 dermatome. The patient has diminished reflexes in the left knee and ankle. The patient's gait is steady with assistance.

Preoperative Imaging Studies:

MRI of the lumbar spine demonstrates degenerative disc disease at L4-L5 and L5-S1, facet joint hypertrophy, and spinal stenosis.

Proposed Surgery:

The patient is a candidate for lumbar spine fusion surgery (LAF-L5-S1) with instrumentation.

Postoperative Course:

The patient underwent successful lumbar spine fusion surgery (LAF-L5-S1) with instrumentation. The patient's postoperative recovery was uneventful, with resolution of preoperative symptoms. The patient was discharged home on postoperative day 4 with instructions for wound care and pain management.

Complications:

The patient did not experience any complications during the postoperative period.

Discharge Medications:

The patient was discharged home on the following medications:

* Omeprazole 20mg PO daily for gastroesophageal reflux disease
* Aspirin 81mg PO daily for prevention of cardiovascular disease
* Gabapentin 300mg PO tid for neuropathic pain
* Hydrocodone 10/325mg PO q4-6h PRN for pain
* Celecoxib 200mg PO bid for pain management

Follow-up:

The patient will follow up with the surgeon in 2 weeks for wound check and removal of sutures. The patient will also follow up with the pain management team for further optimization of pain medications.